Michot, Nicolas
Souadka, Amine
Soufi, Mehdi
Sabbagh, Charles
Lahnaoui, Oumayma
Venara, Aurélien
Lakkis, Zaher
Badic, Bogdan
Mouatassim, Zakaria El
Gagnière, Johan
Duchalais, Emilie
Christou, Niki
Martin, Bertrand
Bouazizi, Yassine El
Mège, Diane
Maggiori, Léon
Hassouni, Mohamed Reda El
Lefèvre, Jérémie
Manceau, Gilles
Beyer, Laura
Bridoux, Valérie
Alves, Arnaud
Houmada, Amina
Moskowitz, David
Souiki, Tarik
Piessen, Guillaume
Salamé, Ephrem
Souadka, Abdellilah
Giger-Pabst, Urs
Ouaissi, Mehdi https://orcid.org/0000-0002-0906-4428
,
Article History
Received: 16 May 2026
Accepted: 6 August 2026
First Online: 11 August 2026
Declarations
Ethics approval and consent to participate: This study was conducted in accordance with the principles of the Declaration of Helsinki. Because the study used anonymous, non-identifiable data, it was exempt from Institutional Review Board (IRB) approval under the applicable regulations (The General Data Protection Regulation (GDPR) and French Law No. 78–17). The study was approved by the Institutional Review Board of the National Institute of Oncology, Rabat, Morocco. Given the retrospective observational design, the use of routinely collected coded data, and the minimal risk to participants, the requirement for individual informed consent was waived by the Institutional Review Board. The study was conducted in accordance with the Declaration of Helsinki and Moroccan Law No. 28–13. Participation was voluntary, and completion of the questionnaire constituted informed consent.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.